PI 3-kinase and cancer: changing accents
- 28 February 2009
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Genetics & Development
- Vol. 19 (1), 12-17
- https://doi.org/10.1016/j.gde.2008.11.011
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- PTEN-deficient cancers depend on PIK3CBProceedings of the National Academy of Sciences of the United States of America, 2008
- Discovery of Drug-Resistant and Drug-Sensitizing Mutations in the Oncogenic PI3K Isoform p110αCancer Cell, 2008
- Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesisNature, 2008
- The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γProceedings of the National Academy of Sciences of the United States of America, 2008
- Tenets of PTEN Tumor SuppressionCell, 2008
- Helical domain and kinase domain mutations in p110α of phosphatidylinositol 3-kinase induce gain of function by different mechanismsProceedings of the National Academy of Sciences of the United States of America, 2008
- Rare cancer-specific mutations in PIK3CA show gain of functionProceedings of the National Academy of Sciences of the United States of America, 2007
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006